Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclobenzaprine for Sleep Disturbance in Breast Cancer Patients on Aromatase Inhibitors
NCT01921296Phase 2Terminated
- Start
- Aug 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclobenzaprine in insomnia disorder, fatigue, pain. Started Aug 2013; status: terminated.
02
Drugs
cyclobenzaprine
03
Conditions
insomnia disorderfatiguepain
Beyond the preview
Go deeper on NCT01921296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921296.